Dr. Paul Samuel Martin, MD

Dr. Martin practices at Breast Imaging Clinic at UW Medical Center Northwest - HOPD in Seattle, Washington.

Dr. Martin's NPI, 1295056323, was assigned on June 11, 2010. Dr. Martin graduated from University of Washington School of Medicine in 2010. Dr. Martin holds Washington license 60375660.

Dr. Martin's primary practice is Breast Imaging Clinic at UW Medical Center Northwest - HOPD, at 1560 N 115th St, Seattle, WA 98133.

Dr. Martin's primary practice is Breast Imaging Clinic at UW Medical Center Northwest - HOPD in Seattle, Washington. Dr. Martin is also affiliated with Fred Hutchinson Cancer Center. The medical group on file is UW Physicians. Dmand AI also links Dr. Martin to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Martin practices, 4 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Martin's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Martin is licensed in Washington.

CMS data shows 1,224 Medicare services from Dr. Martin across 7 procedure codes in 2024, for 231 Medicare patients. Medicare paid $71,913 for them. Every service was in an office.

CMS counts 231 Medicare patients who saw Dr. Martin in 2024. The largest group is 65 to 74, with 94 patients. 71% of them have high blood pressure, and 66% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.94, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Martin's median patient age at 71, with 49% women.

In 2024, Dr. Martin wrote 1,014 Medicare Part D claims for 126 patients. 69% of them were for generic drugs. CMS names the drug for 806 of them, across 26 drugs with 11 or more claims each, at $3,224,810 in total drug cost. In 2023, CMS named 838 claims across 25 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Martin for performance year 2024, reported through an alternative payment model (APM). Dr. Martin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Martin as offering telehealth.

CMS Open Payments shows 4 general payments to Dr. Martin from 3 drug and device companies from 2017 to 2025. Education make up the largest share, 82% of the total. AstraZeneca Pharmaceuticals LP paid the most, $43.

Dr. Martin graduated from University of Washington School of Medicine in 2010.